Adrenergic Pharmacology Flashcards

1
Q

Selected α1-adrenergic receptor roles

α1A

α1B

α1D

Signal transduction mechanisms

A

Stimulation of PLC and calcium release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

α1A

Major roles

A

Cardiac hypertrophy

Prostate smooth muscle contraction

Urethral smooth muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

α1B

Major roles

A

Contraction mesenteric arteries

Growth of adventitia after balloon-injury

Cardiac hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

α1D

Major role

A

Contraction mesenteric arteries

Contraction of coronary/femoral arteries

Contraction of the bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

α2A

Signal Transduction Mechanism

Major effects

A

(Stimulates GIRK channel Inhibits L- and N-type VOCC)

(Inhibition of sympathetic outflow and NE release

Inhibition of insulin secretion

anesthetic-sparing effects )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

α2A cont.

Signal Transduction Mechanism

Major role

A

Inhibits adenylyl cyclase

Decreased lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

α2A cont.

Signal Transduction Mechanism

Major effects

A

Stimulates Na/H+ exchanger

Intestinal absorption of Na and water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

α2A

Signal Transduction Mechanism

(Major effects)

ALL

A

(Stimulates GIRK channel

Inhibits L- and N-type VOCC)

~~(Inhibition of sympathetic outflow and NE release. Inhibition of insulin secretion anesthetic-sparing effects )

Inhibits adenylyl cyclase (Decreased lipolysis)

Stimulates Na/H+ exchanger (Intestinal absorption of Na and water)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

α2B

Signal Transduction Mechanism

Major effects

A

Stimulates GIRK channel

Inhibits N-type VOCC

Analgesia, Sedation

Salt induced hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

α2B CONT

Signal Transduction Mechanism

Major effects

A

Stimulates L-type VOCC

Contraction of some visceral arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

α2B CONT

Signal Transduction Mechanism

Major effects

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

**α2B **

Signal Transduction Mechanism

Major effects

All

A

Stimulates GIRK channel

Inhibits N-type VOCC

(Analgesia, Sedation Salt induced hypertension)

Stimulates L-type VOCC

(Stimulates L-type VOCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

α2C

Signal Transduction Mechanism

Major effects

A

Stimulate GIRK channel.

Inhibit N-type calc channel

(CNS presynaptic inhibition

Inhibition of adrenal catecholamine release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

α2C

Signal Transduction Mechanism

Major effects

A

Stimulates L-type VOCC

(Contraction of cutaneous, mesenteric, and sephanous veins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

α2C

Signal Transduction Mechanism

Major effects

All

A

Stimulate GIRK channel

Inhibit N-type calc channel

  • (CNS presynaptic inhibition*
  • Inhibition of adrenal catecholamine release)*

Stimulates L-type VOCC

Contraction of cutaneous, mesenteric, and sephanous veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

β1

Signal transduction Mechanisms

A

Stimulates adenylyl cyclase

and L-type VOCC

Stimulates funny current

Stimulates SERCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

β1

Major roles

A

Stimulation of renin secretion

Reduction in heart cycle length

Stimulation of myocardial contraction

Hastens heart relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

β2

Signal transduction Mechanisms

A

Stimulates adenylyl cyclase and L-type VOCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

β2

Major roles

A

Relaxation of smooth muscles

Relaxation of bronchioles

Reduction in heart cycle length

Stimulation of myocardial contraction

Hastens myocardial relaxation

Lipolysis

Glycogenolysis

Stimulation of muscle anabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

β3

Signal transduction Mechanisms

A

Stimulates adenylyl cyclase

Stimulates NO production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

β3

Major roles

A

Relaxation of bladder

Relaxation of smooth muscles

Reduction of myocardial contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

epinephrine (Adrenalin, Epipen)

Clinical uses

Pharmacologic effects

A

Clinical uses

hypersensitivity reaction, anaphylaxis, coupled with defibrillatory in cardiac arrest

hemostatic agent or with local anesthetics

peptic ulcer/gastrointestinal bleeding

nasal congestion, asthma

mydriasis for eye surgery

Pharmacologic effects

bronchodilation (β2)

vasoconstriction (α1) (α2)

cardiac stimulation (β1)

mydriasis (α1)

23
Q

epinephrine (Adrenalin, Epipen)

Advantages

Precautions, adv reactions, interactions

A

Advantages

Act quick and for a short period of time

Precautions, adv reactions, interactions

no real contraindication in life-threatening situations

no Bronchodilatation in the presence of β-blockers

Cause hypertension in presence of β-blockers,

Avoid if patient takes MAO/COMT inhibitors

24
Q

norepinephrine (Levophed)

Clinical uses

Pharmacologic effects

A

Clinical uses

neurogenic shock

sepsis

Pharmacologic effects

vasoconstriction (α1) (α2)

cardiac stimulation (β1)

25
**norepinephrine (Levophed)** Advantages Precautions, adv reactions, interactions
**Advantages** acts quick and for a short period of time Preferred to epinephrine, dobutamine, vasopressine, but any of those works. However, dopamine which was traditionally used increase mortality rate significantly **Precautions, adv reactions, interactions** no real contraindication in life-threatening situations
26
**phenylephrine** Clinical uses Pharmacologic effects
*Non-selective, yet favoring a1* **Clinical uses** Nasal and eye congestion Allergic conjunctivitis Phenylephrine can be used for emergency hypotension **Pharmacologic effects** vasoconstriction (a1) mydriasis (a1)
27
**phenylephrine** Advantages Precautions, adv reactions, interactions
**Advantages** vasoconstriction is rapid and intense Oxymetazoline has the highest efficacy Phenylephrine has less central effects **Precautions, adv reactions, interactions** not for prolonged relief (\<10 days) rebound congestion (tachyphylaxis)
28
**midodrine (Amatine, ProAmatine)** Clinical uses Pharmacologic effects
**Clinical uses** chronic orthostatic hypotension hypotension due to autonomic neuropathy **Pharmacologic effects** Vasoconstriction (α1)
29
**midodrine (Amatine, ProAmatine)** Advantages Precautions, adv reactions, interactions
**Advantages** **Precautions, adv reactions, interactions** safety not established sufficiently! efficacy not established sufficiently! supine hypertension, pruritus, urinary retention in 10-20% of patients
30
**Oxymetazoline**
Selectivity Non-selective, full a1 and partial a2A High High Very low Very low Very low
31
**clonidine (Catapres, Duraclon)** ## Footnote Clinical uses Pharmacologic effects
**Clinical uses** hypertension cardiovascular symptoms of alcohol/narcotics/opioids withdrawal adjunctive to relieve pain (reduce opioid requirement) adjunctive in anesthesia (reduce anesthetic require) diarrhea **Pharmacologic effects** Decrease sympathetic drive (a2) Increase parasympathic outflow (a2) Decrease norepinephrine release (a2) Analgesia (a2) Sedation (a2) Stimulate intestin
32
**clonidine (Catapres, Duraclon)** ## Footnote Advantages Precautions, adv reactions, interactions
**Advantages** dosing once a day **Precautions, adv reactions, interactions** may cause CNS depression may reduce attentional performance may cause sexual dysfunction in men prone to rebound hypertension at withdrawal Embryotoxic!
33
**guanfacin (Intuniv,Tenex)** **and ganabenz (Wytensin)** **Clinical uses** **Pharmacologic effects**
**Clinical uses** Hypertension ADHD (in children only, is not a stimulant **Pharmacologic effects** Decrease sympathetic drive (a2) Increase parasympathic outflow (a2) Decrease norepinephrine release (a2)
34
**guanfacin (Intuniv,Tenex)** **and ganabenz (Wytensin)** **Advantages** **Precautions, adv reactions, interactions**
**Advantages** The a2A selectivity of Guanfacine does not impair attentional performance: clonidine and guanabenz do **Precautions, adv reactions, interactions** Caution in hypotention, cardiovascular and cerebrovascular disease, liver and renal impairement Avoid use in elderly may cause hypotension (\<10 %), bradycardia (\<2%), and sedation (5-45%) Subject to rebound hypertension Avoid combination with CYP inhibitors, sedatives, hypnotics, antidepressants, benzodiazepines
35
**methyl-dopa (Aldomet, Aldoril, Dopamet)** ## Footnote Clinical uses Pharmacologic effects
**Clinical uses** Moderate to severe hypertention Pregnancy-induced hypertension Severe pre-eclampsia hypertension during pregnancy **Pharmacologic effects** decrease sympathetic drive (a2) increase parasympathetic outflow (a2) decrease norepinephrine release (a2)
36
**methyl-dopa (Aldomet, Aldoril, Dopamet)** ## Footnote Advantages Precautions, adv reactions, interactions
**Advantages** Not embryotoxic: clonidine, ganfacine and guanabenz are! **Precautions, adv reactions, interactions** avoid with liver and kidney diseases Avoid in elderly because of CNS and cardiovascular effects may cause liver and kidney toxicity CNS depression Hypotension and bradycardia
37
**apraclonidine (Iopidine)** **and brimonidine (Alphagan)** Clinical uses Pharmacologic effects
**Clinical uses** Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension **Pharmacologic effects** Reduction of aqueous humor (a2)
38
**apraclonidine (Iopidine)** **and brimonidine (Alphagan)** Advantages Precautions, adv reactions, interactions
**Advantages** Apraclonidine don’t cross blood-brain **Precautions, adv reactions, interactions** CNS depression (5%), especially children (25-85%) allergic conjunctivitis (\>10%), visual disturbance (5-10%), Burning sensation (5-10%) Dry mouth (5-10%)
39
**Isoproterenol (Isuprel)** ## Footnote Clinical uses Pharmacologic effects
Isoproterenol Low Low High High high Non-selective b **Clinical uses** cardiac resuscitation Acute heart failure **Pharmacologic effects** Cardiac stimulation (b1) Bronchodilation (b2) Vasodilatation (b2) (b3)
40
**Isoproterenol (Isuprel)** ## Footnote Advantages Precautions, adv reactions, interactions
**Advantages** Efficacy better than Dobutamine, but does it worth the risks! **Precautions, adv reactions, interactions** Avoid with preexisting angina, tachyarrhythmias, coronary artery disease, diabetes, distributive shocks May cause angina, hyper/hypotension, tachyarrhythmias, hypokalemia, hyperglycemia, dypnea, pulmonary edema …. Cardiac ischemia may occur
41
**Dobutamine (Dobutrex)** ## Footnote Clinical uses Pharmacologic effects
**Clinical uses** Acute heart failure Cardiogenic shock **Pharmacologic effects** Cardiac stimulation (α1, b1) Vasoconstriction (α1) **Advantages** Increase cardiac output with little vasoconstriction compared to NEPI **Precautions, adv reactions, interactions** Similar to isoproterenol, but with a much lower incidence
42
**albuterol (Ventolin, Proventil, AccuNeb, Vospire) and** **Terbutaline (Brethine, Bricanyl)** **B2**
**Clinical uses** asthma **Pharmacologic effects** Bronchodilatation (b2) **Advantages** Act quick **Precautions, adv reactions, interactions** tremors, restlessness hypotension, tachycardia hyperglycemia, hyperlipidemia decreases concentration of K
43
**Salmeterol (Serevent, Seretide\*, Advair\*\*) and** **Formoterol (Foradil,Symbicort\*)**
**Clinical uses** adjunctive treatment of asthma Prevention/not treatment of exertion-induced bronchospasm **Pharmacologic effects** Bronchodilatation (b2) **Advantages** Only for uncontrolled asthma Salmeterol is 10000X more lipophilic than Albuterol Formoterol has low efficacy toward internalization of the receptor **Precautions, adv reactions, interactions** Same as Albuterol May increase asthma-related death!
44
**Phenoxybenzamine (Irreversible a antagonist) and** **Phentolamine (Non-selective a antagonist)**
**Clinical uses** Preoperative in pheochromocytoma (both) Adjunctive treatment if pheochromocytoma is inoperable Prevention of necrosis in case of extravasation of sympathomimetics **Pharmacologic effects** hypotension (α1) vasodilatation of arteries and veins (α1) depression baroreflex (α1) **Advantages** phentolamine is reversible **Disadvantages** effects of phenoxybenzamine last more than 24 hrs hypotension, tachycardia extreame nasal stuffiness
45
**Prazosin a1** **Doxazosin a1** **Antagonist **
**Clinical uses** benign prostate hyperplasia alternative treatment of hypertension **Pharmacologic effects** hypotension (α1) relaxation of smooth muscle (α1) depression baroreflex (α1) **Advantages** Terazosine and Doxazosin are taken once daily **Disadvantages** Prazosin needs to be taken several times/day very strong first dose effect! dizziness 50%, even syncope Nasal stuffiness Hypotension, tachycardia
46
**Alfuzosin** **Silodosin** **a1 antagonist **
**Clinical uses** benign prostate hyperplasia **Pharmacologic effects** relaxation of prostate smooth muscle (α1) **Advantages** Selective for prostate lesser first dose effects Alfuzosin also induce apoptosis of prostate smooth muscle **Disadvantages** Same side effects as prazosin, but in less patients and to a lesser degree
47
**propranolol (Na channel blockade)** **timolol (No)** Selective for b1, b2
**Clinical uses** Adjunctive or alternative treatment of hypertension Angina pectoris tachycardia Myocardial infarction Timolol is used for intraocular hypertention Propranolol is used for situational anxiety **Pharmacologic effects** Reduction of heart rate (β1) Reduction of ventricular contraction (β1) Reduction of renin release (β1) \*Reduce aqueous humor (?) Reduce anxiety (β1 and others) **Advantages** They “work” !!! Especially propranolol Timolol may be less prone to side effects **Precautions, adv reactions, interactions** Cross BBB and cause dizziness (\<10%), insomnia (\<5%), depression (\<5%) May cause Bradycardia, Heart failure, Bronchospasms May potentiate, and mask, signs of hypoglycemia in diabetic May prevent effect of epinephrine in anaphylaxis These effects are more prevalent for propranolol
48
**pindolol** **Selective for b1, b2** **Antagonsit ** Partial β1 agonist Partial β3 agonist Na channel blockade NO production
**Clinical uses** Adjunctive abd alternative treatment of hypertension Alternative treatment of hypertension Tachycardia Situational anxiety **Pharmacologic effects** Reduction of heart rate (partial β1 agonist) Reduction of ventricular contraction (partial β1 agonist) Reduction of renin release (partial β1 agonist) Vasodilatation ( partial β3 agonist) **Advantages** Maintains partial receptor functions Marginally affects basal, but prevents the consequence of elevated sympathetic drive Less subject to rebound tachycardia & hypertension **Precautions, adv reactions, interactions** “Lesser efficacy” than propranolol, \>\>\> yet slightly higher prevalence of side effects Insomnia (\> 10%), dizziness (\<10%), fatigue (\<10%) and depression (up to 8%)
49
**bisoprolol no** **metoprolol (Na channel blockade +/-)** **Selective for b1 Antagonist**
**Clinical use** Adjunctive or alternative treatment of hypertension Angina pectoris Metoprolol is used in hemodynamically stable, acute myocardial infarction (iv) reduces mortality/hospitalization in patients with heart failure in patient already receiving ACE inhibitors, diuretics, and/or digoxin **Pharmacologic effect (Receptor)** Reduction of heart rate (β1) Reduction of ventricular contraction (β1) Reduction of renin release (β1) **Side effects and drug interactions** Metabolism and kinetic Hypotension, Bradychardia Dizziness or Fatigue More with Metroprolol Metoprolol cross BBB
50
**Esmolol no** **Selective for b**
**Clinical use** Intraoperative tachycardia Supraventricular tachycardia Atrial fibrillation/flutter SVT and post-operative hypertension in children **Pharmacologic effect (Receptor)** Reduction of heart rate (β1) Reduction of ventricular contraction (β1) **Side effects and drug interactions** None that will last Hypotension (less than 10%)
51
**Nebivolol** ## Footnote Best b1 over b2 selectivity Moderate β3 Partial β3 agonist **NO production**
**Clinical uses** Adjunctive treatment of hypertension Alternative treatment of hypertension stable Heart failure **Pharmacologic effects** Reduction of heart rate (β1) Reduction of ventricular contraction (β1) Vasodilatation (partial β3 agonist, which activate nitric oxide synthase) Antioxidant (NADPH oxidase inhibitor) **Advantages** Well tolerated Marginally more potent than the first generation Promotes NO release (an advantage in elderly) **Precautions, adv reactions, interactions** headache (\< 10%), dizziness (\<5%), fatigue (\<5%)
52
**labetolol** ## Footnote Weakest selectivity, but favors b1, b2 Partial β2 agonist Partial β3 agonist\* a1 antagonist Na channel blockade NO production
**Clinical use** Adjunctive treatment of hypertension Alternative treatment of hypertension Hypertensive emergency Pediatric hypertension hypertension of pregnancy **Pharmacologic effect (Receptor)** Reduction of heart rate (β1) Reduction of ventricular contraction (β1) Not as much as propranolol Vasodilatation (α1) (β2) (β3) Side effects and drug interactions Hypotension (up to 58%) dizziness (up to 20%) Nausea (up to 19%) Fatigue (up to 11%) **Metabolism and kinetic** Negligible amount cross BBB
53
**Carvedilol** **Weakest selectivity, but favors b1, b2** a1 antagonist Na channel blockade Ca channel blockade
**Clinical use** Adjunctive treatment of hypertension Alternative treatment of hypertension Mild to severe heart failure Left ventricular dysfunction following myocardial infarction Angina pectoris **Pharmacologic effect (Receptor)** Reduction of heart rate (β1) Reduction of ventricular contraction (β1) Vasodilatation (α1) Antioxidant Anti-proliferative **Side effects and drug interactions** Dizziness (up to 30%) Fatigue (up to 24%) Hypotension (up to 20%) Weight gain and diarrhea (up to 12%) Weakness, bradychardia (up to 10%) **Metabolism and kinetic** Cross BBB
54